cognitive cybersecurity intelligence

News and Analysis

Search

Merck-Moderna vaccine helps reduce chances of skin cancer

A vaccine launched by Merck and Moderna was found to reduce the chances of skin cancer when used with the drug Keytruda, according to a new study released Monday.

The new results found that 79 percent of participants who received the vaccine and Keytruda stayed cancer-free for 18 months…

Source: thehill.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts